Signal Transduction and Targeted Therapy: A Comprehensive Guide to Research Scope

‘Signal Transduction and Targeted Therapy’ is an open-access, peer-reviewed academic journal jointly sponsored by the Shanghai Institute of Life Sciences, Chinese Academy of Sciences, and the National Natural Science Foundation of China. The journal’s primary research scope encompasses two key areas: signal transduction and targeted therapy.

Signal transduction refers to the process of transmitting signals both inside and outside cells, playing a crucial role in cell biology and physiology. The journal covers all aspects of signal transduction, including but not limited to the discovery and research of cell signaling pathways, the structure and function of signaling molecules, the regulatory mechanisms of signaling networks, and the roles of signal transduction in biological development, immune regulation, metabolic regulation, and other physiological processes.

Targeted therapy is a treatment approach based on specific molecular targets, achieving therapeutic effects by selectively acting on disease-related molecular targets. The journal focuses on the latest research advancements in targeted therapy, including but not limited to the discovery and design of targeted drugs, mechanism studies of targeted therapy, clinical applications of targeted drugs, and efficacy assessments.

Overall, the journal aims to promote scientific research and technological innovation in the fields of signal transduction and targeted therapy, providing a platform for the academic community to exchange and share the latest research findings.